InvestorsObserver is giving Histogen Inc (HSTO) an Analyst Rating Rank of 78, meaning HSTO is ranked higher by analysts than 78% of stocks. The average price target for HSTO is $5 and analyst’s rate the stock as a Strong Buy
Why are Analyst Ratings Important?
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What's Happening With Histogen Inc Stock Today?
Histogen Inc (HSTO) stock is trading at $1.48 as of 9:59 AM on Monday, Mar 15, a rise of $0.13, or 9.26% from the previous closing price of $1.35. The stock has traded between $1.43 and $1.55 so far today. Volume today is less active than usual. So far 3,519,763 shares have traded compared to average volume of 5,090,118 shares.
Click Here to get the full report on Histogen Inc (HSTO) Stock.
